Botox study and facial Anesthetic Infiltration on the Tinnitus Intensity in Patients with Temporomandibular Disorders
- Conditions
- C09.218.458.670F01.145.126.990Temporomandibular Joint Disorders, Otoneurological Diseases, Quality of Life, BruxismC07.793.099C05.500.607.221.897.897
- Registration Number
- RBR-73jdz5
- Lead Sponsor
- Hospital Universitário Professor Edgard Santos/UFBA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- Not specified
Temporomandibular joint disorder diagnosis; otoneurologic symptoms for at least three months; at least 15 years of age; both genders; no current treatment for temporomandibular disorder or otoneurologic disease.
Allergy to lidocaine or botulinum toxin; anyone who changed therapies during the study to avoid false-positive; imunossupressed patients; diabetes mellitus; cognitive impairment; pregnancy or breast feeding; psychiatric disorders; skin conditions; clotting disturbances; neuromuscular diseases; using clacium channel blokers; antibiotics (aminoglycosides); cyclosporin; chloroquines; hydroxichloroquine; D-penicillamine; or anu=y other substance that interferes with neuromuscular transmission; Myasthenia gravis; Eaton Lambert syndrome; Amyotrophic sclerosis; or any disturbances that promote periferal neuromuscular dysfunction; oral anticoagulante; derivates from acetylsalicylic acid; derivates from vitemin E ou Ginko Biloba
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcome was a reduction of at least 30% in the intensity of tinnitus determined through a questionnaire, at any intensity when compared to the initial condition, to verify whether the outcome actually happened.
- Secondary Outcome Measures
Name Time Method Secondary outcomes are not expected